Carl Zeiss Meditec: Was macht der CEO mit 670 Mio. Euro? Aktienanalyse

Ludwin Monz, CEO von Carl Zeiss Meditec verwöhne seine Anteilseigner immer wieder mit neuen Rekorden und einem robusten Zahlenwerk.
(Orginal – Story lesen…)

This website stores some user agent data. These data are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to opt-out of any future tracking, a cookie will be set up in your browser to remember this choice for one year. I Agree, Deny
646